SAN DIEGO, June 5 /PRNewswire/ -- ChemDiv announced today the continuation of multi-year collaboration with Schering Plough Corporation. In the framework of this collaboration ChemDiv will provide Schering Plough with a set of chemical libraries that will be produced through parallel synthesis based on the customer selected templates. In accordance with the agreement teams of ChemDiv and Schering Plough scientists will work closely to develop exclusive small molecule libraries enhancing Schering Plough’s global drug discovery effort. Further details and financial terms were not disclosed.
“ChemDiv is excited to be working with Schering Plough a pioneer of pharmaceutical industry that is working to improve people’s health and extend lives. Their decision to select ChemDiv as their drug discovery partner underscores the quality of our work, the innovation we bring to our partners and our solid reputation for success in this field,” said Nikolay Savchuk, President and CEO of ChemDiv. “We are committed to expanding our product line to provide more integrated drug discovery services to our clients. We are now engaged in more discovery research programs than ever before, and we look forward to generating value on behalf of our clients.”
About ChemDiv
ChemDiv Inc. (Chemical Diversity) is a global chemistry-driven contract research organization focused on identifying and delivering discovery opportunities and services for life science partners, and merging industrial and academic efforts to bring new approaches to the treatment of life-threatening diseases. For further information please visit http://www.chemdiv.com.
CONTACT: Bill Farley, Sr. Director Business Development of ChemDiv Inc.,
+1-516-318-2150, bf@chemdiv.com
Web site: http://www.chemdiv.com/
